tiprankstipranks
Protara Therapeutics (TARA)
NASDAQ:TARA
Holding TARA?
Track your performance easily

Protara Therapeutics (TARA) Financial Statements

582 Followers

Protara Therapeutics Financial Overview

Protara Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.821; its P/E ratio is -1.07; Protara Therapeutics is scheduled to report earnings on March 5, 2025, and the estimated EPS forecast is $-0.59. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -11.22M$ -9.51M$ 12.61M$ -11.04M$ -10.70M
EBITDA$ -11.21M$ -9.19M$ 12.87M$ -10.93M$ -10.62M
Net Income Common Stockholders$ -11.22M$ -9.51M$ -11.10M$ -10.22M$ -9.86M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 81.50M$ 89.58M$ 55.22M$ 65.58M$ 74.03M
Total Assets$ 94.09M$ 101.65M$ 68.13M$ 78.95M$ 88.47M
Total Debt$ 4.74M$ 4.98M$ 5.23M$ 5.47M$ 5.70M
Net Debt$ -76.76M$ -84.60M$ -50.00M$ -60.11M$ -68.33M
Total Liabilities$ 12.30M$ 9.60M$ 9.73M$ 10.63M$ 11.51M
Stockholders Equity$ 81.79M$ 92.05M$ 58.41M$ 68.32M$ 76.96M
Cash Flow-
Free Cash Flow$ -8.44M$ -7.74M$ -10.38M$ -8.70M$ -6.60M
Operating Cash Flow$ -8.43M$ -7.69M$ -10.38M$ -8.70M$ -6.56M
Investing Cash Flow$ -29.39M$ 2.94M$ 23.10M$ 14.52M$ 6.38M
Financing Cash Flow-$ 42.09M$ -76.00K-$ -27.00K
Currency in USD

Protara Therapeutics Earnings and Revenue History

Protara Therapeutics Debt to Assets

Protara Therapeutics Cash Flow

Protara Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis